§ 3.2-6591. Definitions
§ 3.2-6592. Manufacturers and contract testing facilities required to use alternative test methods when available
§ 3.2-6593. Enforcement; civil action; penalty
§ 3.2-6593.1. Animal testing facilities; adoption of dogs and cats
As used in this article, unless the context requires a different meaning:
“Alternative test method” means a test method that (i) provides information of equivalent or better scientific quality and relevance than animal test methods, (ii) has been identified by a validation body and adopted by the relevant federal agency or program within an agency responsible for regulating the specific product or activity for which the test is being conducted, and (iii) does not use animals, or, when there is no test method available that does not use animals, uses the fewest animals possible and reduces the level of suffering or stress, to the greatest extent possible, of an animal used for testing. “Alternative test method” includes computational toxicology and bioinformatics, high-throughput screening methods, testing of categories of chemical substances, tiered testing methods, in vitro studies, and systems biology and new or revised methods.
“Animal” means any live vertebrate nonhuman animal.
“Animal test method” means a process or procedure that uses animals to obtain information on the characteristics of a chemical or agent or the biological effect of exposure to a chemical or agent under specified conditions.
“Animal testing facility” means any facility, including a private entity, state agency, or institution of higher education, that confines and uses dogs or cats for research, education, testing, or other scientific or medical purposes.
“Contract testing facility” means any partnership, corporation, association, or other legal relationship that tests chemicals, ingredients, product formulations, or products on behalf of another entity.
“Manufacturer” means any partnership, corporation, association, or other legal entity that produces chemicals, ingredients, product formulations, or products.
“Validation body” means an organization that seeks to facilitate development, validation, and regulatory acceptance of new and revised regulatory test methods that reduce, refine, or replace the use of animals in testing, such as the Interagency Coordinating Committee on the Validation of Alternative Methods or other similar organizations.
Added by Acts 2018, c. 672. Amended by Acts 2021, Sp. S. I, c. 340, eff. July 1, 2021.
A. No manufacturer or contract testing facility shall use an animal test method when an alternative test method is available.
B. Nothing in this section shall prohibit the use of a test method that does not use animals.
C. This section shall not apply to any manufacturer or contract test facility using an animal test method for the purpose of medical research related to the causes, diagnosis, treatment, control, or prevention of physical or mental diseases and impairments of humans and animals, or related to the development of devices or drugs, as those terms are defined in 21 U.S.C. § 321, biomedical products, or any other products regulated by the U.S. Food and Drug Administration, except for any product regulated under Subchapter VI of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.). Such medical research does not include the testing of an ingredient that (i) was formerly used in a drug; (ii) was tested for use in a drug using commonly accepted animal testing methods to characterize the ingredient and to substantiate its safety for human use; and (iii) is proposed for use in a product other than a biomedical product, medical device, or drug.
Added by Acts 2018, c. 672.
The Attorney General may bring a civil action in the appropriate circuit court for injunctive relief to enforce the provisions of this article. Any person who violates any provision of this article may, upon such finding by an appropriate circuit court, be subject to a civil penalty of not more than $5,000 and any court costs and attorney fees. Such civil penalties shall be paid into the state treasury.
Added by Acts 2018, c. 672.
Any animal testing facility that no longer has need for a dog or cat in its possession that does not pose a health or safety risk to the public or welfare of the animal shall (i) offer for release such dog or cat to a releasing agency for eventual adoption or for adoption through a private placement or (ii) in the case of a testing facility operated by an agency or institution of higher education, develop its own adoption program, provided that such program maintains records that comply with § 3.2-6557. Such animal testing facility shall keep such offer for release open for a reasonable length of time, up to three weeks, prior to euthanizing such dog or cat. An animal testing facility may enter into an agreement with a releasing agency for the implementation of the provisions of this section.
An animal testing facility shall not be liable for any harm caused by or any defect suffered by any dog or cat adopted pursuant to this section.
Added by Acts 2021, Sp. S. I, c. 340, eff. July 1, 2021.